Hydrocephalus
Conditions
Keywords
Cerebrospinal Fluid Shunts, Randomized Controlled Trial
Brief summary
The purpose of the study is to compare the survival time (time to first shunt failure) of ventriculoperitoneal (VP) shunts inserted through an anterior entry site with those inserted through a posterior entry site in children. Shunt entry site is the location on the head that the shunt catheter enters the brain on its path to the fluid-filled spaces in the brain, the ventricles. Entry sites can be anterior or posterior.
Detailed description
The study is a multi-centered, randomized, controlled trial comparing two commonly used CSF shunt insertion techniques, anterior and posterior entry site. There is conflicting information and opinions in the pediatric hydrocephalus literature regarding entry site's effect on shunt survival. This trial is designed to detect a 10% or more difference in the rate of shunt survival at one year between the two techniques. The trial will be conducted by the Hydrocephalus Clinical Research Network and the Hydrocephalus Association. It is a four year study with an estimated sample size of 448 patients. Patients will be randomized in the operating room. Subjects will be followed for a minimum of 18 months.
Interventions
PROCEDUREVentriculoperitoneal shunt insertion surgery
The most common treatment for hydrocephalus is the placement of a ventriculoperitoneal shunt in the operating room. A shunt is a flexible tube placed into the ventricular system, fluid filled chambers, of the brain that diverts the flow of CSF into another region of the body, usually the abdomen, also known as the peritoneal cavity, where it can be absorbed.
Sponsors
Patient-Centered Outcomes Research Institute
University of Alabama at Birmingham
University of British Columbia
University of Pittsburgh
University of Toronto
University of Utah
University of Washington
Vanderbilt University
Washington University School of Medicine
Hydrocephalus Association
Ohio State University
Johns Hopkins University
University of Calgary
University of Colorado, Denver
University of Southern California
Baylor College of Medicine
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)
Masking description
Adjudication committee reviews blinded notes, data collection forms, and films to determine shunt failure.
Intervention model description
1 to 1 randomized trial comparing two commonly used shunt insertion entry sites.
Eligibility
Sex/Gender
ALL
Age
1 Days to 17 Years
Healthy volunteers
No
Inclusion criteria
1. Less than 18 years of age at the time of shunt insertion; AND 2. Clinical evidence of hydrocephalus that requires a simple ventriculoperitoneal shunt as determined by a pediatric neurosurgeon; AND 3. No prior history of shunt insertion (a history of an external ventricular drain, ventricular reservoir, subgaleal shunt, and or endoscopic third ventriculostomy with or without choroid plexus coagulation is permissible); AND 4. Ventriculomegaly on imaging.
Exclusion criteria
1. Need of a shunt that is not a simple ventriculoperitoneal shunt. For example: Patients who require more than one intracranial catheter are excluded. Patients who require a ventricular shunt that terminates in the atrium of the heart, the pleural cavity, the gallbladder, or any other terminal location that is not the peritoneal cavity are excluded. Patients who require a subdural to peritoneal or a cyst to peritoneal shunt are excluded. 2. Active CSF or abdominal infection; 3. CSF leak without hydrocephalus; 4. Pseudotumor cerebri; 5. Hydranencephaly; 6. Loculations within the ventricular system (e.g. large intraventricular cysts or ventricular adhesions which create compartments that distort the ventricular anatomy; isolated trapped lateral ventricle). A small cyst within the ventricle does not meet these criteria; 7. Other difficulties that would preclude follow up at one year (e.g. terminal illness with life expectancy less than 18 months; family plans to move out of region or country); 8. A bilateral scalp, bone, or ventricular lesion that makes placement of either an anterior or a posterior shunt impracticable (e.g. cutis aplasia); 9. Bilateral slit like frontal horns or trigones defined as the widest distance between the medial and lateral walls less than 3 millimeters. 10. Patient is scheduled to have an intra-ventricular procedure (e.g. ETV, endoscopic biopsy, arachnoid cyst fenestration, fenestration of septum pellucidum) in addition to possible or definite VP shunt.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Shunt Failure determined by clinical and radiographic findings | Within 18 months to 44 months from shunt insertion surgery | Shunt failure occurs when the shunt is obstructed, infected, over-drains, or does not drain the entire ventricular system. Shunt failure will be confirmed by radiographic and/ or operative findings, and all failures will be reviewed by a blinded adjudication committee. Subjects will be monitored for shunt failure at each scheduled and unscheduled clinical visit throughout the study. Survival analysis will be used to compare time to shunt failure in each treatment group. The last subject entered into the trial will be followed for 18 months and accrual is expected to take 26 months (maximum follow up 44 months). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Patient quality of life measured by the Pediatric Quality of Life Inventory (PedsQL) | 1 week and 1 year after shunt surgery | A validated quality of life measure will be administered to all subjects/ caretakers at enrollment and at the above time intervals. |
| Duration of surgery (minutes) | Shunt insertion surgery | — |
| Location of ventricular catheter tip on brain imaging | within 1 year of shunt surgery | Position of the ventricular catheter on the first postoperative imaging study will be assessed on postoperative imaging studies obtained within 1 year of shunt insertion surgery. The frequency of catheter tips in poor locations (e.g. within brain parenchyma) will be compared between treatment groups. |
| Number and type of shunt revisions | Within 18 months to 44 months from shunt insertion surgery | The number of shunt revisions required by each subject from the time of shunt insertion to the conclusion of the study will be compared. All subjects will be followed for at least 18 months. |
Countries
Canada, United States
Outcome results
None listed